Global, regional, and national lifetime probabilities of developing cancer in 2020
- PMID: 37821267
- PMCID: PMC10640926
- DOI: 10.1016/j.scib.2023.09.041
Global, regional, and national lifetime probabilities of developing cancer in 2020
Abstract
The lifetime risk of cancer is a measure of the cumulative risk of cancer over a specific age range and has a clear, intuitive appeal. However, comparative assessments of cancer-specific risk across populations are limited. We used the adjusted for multiple primaries method to estimate the lifetime risk of cancer from the obtained data from GLOBOCAN for 185 countries/regions for the year 2020, alongside all-cause mortality and population data from the United Nations. The estimated global lifetime risk of cancer from birth to death was 25.10% (95% confidence interval (CI): 25.08%-25.11%) in 2020; the risk was 26.27% (95% CI: 26.24%-26.30%) in men and 23.96% (95% CI: 23.93%-23.98%) in women. Significant differences were observed in the risks between countries/regions within world areas and by the human development level. The lifetime risk of cancer was 38.48%, 25.38%, 11.36%, and 10.34% in countries/regions with very high, high, medium, and low Human Development Index, respectively. Globally, prostate and breast cancers were associated with the greatest lifetime risks among men and women (4.65% and 5.90%, respectively). The lifetime risk of cancer decreased with age, with a remaining risk of 12.61% (95% CI: 12.60%-12.63%) from the age of 70 years. The lifetime risk from birth to death translates to approximately one in four persons developing cancer, with men and women having similar risk levels. The identified age-specific variations in cancer risk at the population level can provide crucial information to support targeted cancer prevention and health system planning.
Keywords: Burden; Cancer incidence; Epidemiology; Global; Lifetime risk.
Copyright © 2023. Published by Elsevier B.V.
Conflict of interest statement
Conflict of interest The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN.Lancet Gastroenterol Hepatol. 2024 Mar;9(3):229-237. doi: 10.1016/S2468-1253(23)00366-7. Epub 2024 Jan 4. Lancet Gastroenterol Hepatol. 2024. PMID: 38185129 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.Contraception. 1992 Feb;45(2):93-104. doi: 10.1016/0010-7824(92)90043-s. Contraception. 1992. PMID: 1559340
-
Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs.Lancet Oncol. 2022 Jun;23(6):719-728. doi: 10.1016/S1470-2045(22)00270-4. Epub 2022 May 9. Lancet Oncol. 2022. PMID: 35550275 Review.
-
The Minderoo-Monaco Commission on Plastics and Human Health.Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023. Ann Glob Health. 2023. PMID: 36969097 Free PMC article. Review.
Cited by
-
An Efficient Synthesis of 1-(1,3-Dioxoisoindolin-2-yl)-3-aryl Urea Analogs as Anticancer and Antioxidant Agents: An Insight into Experimental and In Silico Studies.Molecules. 2023 Dec 21;29(1):67. doi: 10.3390/molecules29010067. Molecules. 2023. PMID: 38202650 Free PMC article.
-
From Churchill to Elephants: The Role of Protective Genes against Cancer.Genes (Basel). 2024 Jan 18;15(1):118. doi: 10.3390/genes15010118. Genes (Basel). 2024. PMID: 38255007 Free PMC article. Review.
-
Sex-specific associations between habitual snoring and cancer prevalence: insights from a US Cohort Study.Sleep Adv. 2024 Jul 25;5(1):zpae051. doi: 10.1093/sleepadvances/zpae051. eCollection 2024. Sleep Adv. 2024. PMID: 39156215 Free PMC article.
-
Identification of Molecular Subtype and Prognostic Signature for Prostate Adenocarcinoma based on Neutrophil Extracellular Traps.J Cancer. 2024 Mar 17;15(9):2678-2690. doi: 10.7150/jca.93275. eCollection 2024. J Cancer. 2024. PMID: 38577608 Free PMC article.
-
First-line PARP inhibitor maintenance treatment in ovarian carcinoma for older adult women: a review of the current literature.Clin Transl Oncol. 2024 Jul 19. doi: 10.1007/s12094-024-03609-y. Online ahead of print. Clin Transl Oncol. 2024. PMID: 39030437 Review.
References
-
- World Health Organization. Cancer. 2022, https://www.who.int/news-room/fact-sheets/detail/cancer.
-
- Bray F., Colombet M., Mery L., et al. volume XI. IARC Scientific Publication; Lyon: 2021. (Cancer incidence in five continents).
-
- Sung H., Ferlay J., Siegel R.L., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. - PubMed
-
- International Agency for Research on Cancer. Cancer today. 2020, https://gco.iarc.fr/today.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical